New launches to keep growth momentum healthy for Sun Pharma stock
Incremental gains for the company, and the listed pharma universe more broadly, also stemmed from positive sentiment around the India–US trade deal. About a third of Sun Pharma’s revenues come from the US market. Photograph: Francia Mascarenhas/Reuters Key Points The
